In the studied context, a review of six clinical trials found a safety profile comparable to placebo, without the IGF-1 effects of full growth hormone
Why Retatrutide Works for Menopausal Women Retatrutide represents the next generation of weight management medications, offering a unique triple-agonist mechanism that activates three distinct hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
PlexusDx genetic and biomarker insights may help provide context about how your body metabolizes GLP-1 peptides, but consistent medication potency through proper storage is a prerequisite for that personalization to work
Sermorelin is an analogue of growth hormone-releasing hormone (GHRH) and binds to growth hormone-releasing hormone receptors (GHRH-R)
Its primary role is to facilitate cellular energy production and support DNA repair
That score sits in uncomfortable territory, not low enough to scream "avoid," but not high enough to inspire confidence